Belgium: Life Sciences, Biotechnology & Nanotechnology

The European Commission has launched its first formal antitrust investigation in the medical devices sector, examining whether Align Technology may have abused its dominant position by restricting interoperability between its Invisalign clear aligners and competing intra-oral scanners. The investigation focuses on allegations that the company created a closed ecosystem, forcing dental professionals to purchase iTero scanners to access Invisalign products for their patients.

The Biotech Act aims to help Europe in its struggle to translate world-class life sciences research into commercial success by tackling the structural barriers that have driven start-ups abroad...

FAQ explains research exemption, dual conformity assessment and clinical data obligations for devices and diagnostics